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Society foPurpose: Comparedwithmany small circular beams used inCyberKnife treatments, beam’s eye view-shaped fields
are generally more time-efficient for dose delivery. However, beam’s eye view-shaping devices, such as a mini-
multileaf collimator (mMLC), are not presently available for CyberKnife, although a variable-aperture collimator
(Iris, 12 field diameters; 5–60 mm) is available. We investigated whether the Iris can mimic noncoplanar mMLC
treatments using a limited set of principal beam orientations (nodes) to produce time-efficient treatment plans.
Methods and Materials: The data from 10 lung cancer patients and the beam-orientation optimization algorithm
‘‘Cycle’’ were used to generate stereotactic treatment plans (3  20 Gy) for a CyberKnife virtually equipped with
a mMLC. Typically, 10–16 favorable beam orientations were selected from 117 available robot node positions
using beam’s eye view-shaped fields with uniform fluence. Second, intensity-modulated Iris plans were generated
by inverse optimization of nonisocentric circular candidate beams targeted from the same nodes selected in the
mMLC plans. The plans were evaluated using the mean lung dose, lung volume receiving $20 Gy, conformality
index, number of nodes, beams, and monitor units, and estimated treatment time.
Results: The mMLC plans contained an average of 12 nodes and 11,690 monitor units. For a comparable mean
lung dose, the Iris plans contained 12 nodes, 64 beams, and 21,990 monitor units. The estimated fraction duration
was 12.2 min (range, 10.8–13.5) for the mMLC plans and 18.4 min (range, 12.9–28.5) for the Iris plans. In contrast
to themMLC plans, the treatment time for the Iris plans increasedwith an increasing target volume. The Iris plans
were, on average, 40% longer than the corresponding mMLC plans for small targets (<80 cm3) and#121% longer
for larger targets. For a comparable conformality index, similar results were obtained.
Conclusion: For stereotactic lung irradiation, time-efficient and high-quality plans were obtained for robotic-
controlled noncoplanar treatments using amMLC. Iris is a time-efficient alternative for small targets, with similar
or better plan quality.
 2011 Elsevier Inc.
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Excellent local tumor control has been achieved in patients
with early-stage non–small-cell lung cancer treated using the
CyberKnife Robotic Radiosurgery System (Accuray, Sunny-
vale, CA). The CyberKnife consists of a compact 6-MV linear
accelerator mounted on a robotic manipulator and performs
real-time tumor tracking to compensate for respiratorymotion.
Despite the high local tumor control rates, the long treatment
time per fraction is an area for improvement (1).
The fraction duration mainly consists of the beam-on
time, robot motion time, and image guidance time and can
ed by developing time-efficient treatment plans.
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863The beam-on time can be reduced by reducing the number
of monitor units (MUs). The robot motion time—the preva-
lent factor—can be reduced by reducing the number of node
positions and beams. The node positions are the preset
locations where the robotic manipulator can position the
focal spot of the linear accelerator (i.e., the source of the
X-ray beam). From these node positions, multiple beams
can be targeted at various locations in the tumor by adjusting
the orientation of the linear accelerator. Traveling between
node positions takes longer than a reorientation of the linear
accelerator between beams at a node position. The imagingtime is reduced automatically by reducing the overall
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Table 1. Maximal dose constraints for organs at risk and
conformality constraint
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position and tracking accuracy.
The number of node positions, beams, and MUs in a treat-
ment plan can be reduced by increasing the degrees of free-
dom of beam collimation. The CyberKnife at our institute
has 12 collimators with fixed circular apertures ranging
from 5 to 60 mm in diameter. Generally, only one or two col-
limators are used per treatment. Clinical treatment plans typ-
ically contain 60 node positions, 125 beams, and 35,000
MUs. P€oll et al. (1) showed that the number of MUs in
lung cancer treatments could be reduced by an average of
31% if two collimator sizes were used instead of one. An
even larger reduction in the required number of MUs
(60% in lung cancer treatments) was achieved when
a variable-aperture collimator was used (2). This variable-
aperture collimator is called the Iris Variable Aperture Col-
limator (Accuray) and allows 12 field diameters to be used
without the manual exchange of collimators.
A mini-multileaf collimator (mMLC) mounted on the
CyberKnife could lead to even more time-efficient treatment
plans, because it does not restrict the field to a circular field
shape as does the Iris collimator. It allows for three-
dimensional conformal radiotherapy (3D-CRT) to be
performed using fields shaped according to the beam’s eye
view projection of the target. This will make dose painting
with a large number of circular beams superfluous, thereby
reducing the required number of beams and MUs. Moreover,
a mMLC is also expected to require a limited set of node
positions, because a feasible number of beam directions is
10–15 in stereotactic radiotherapy for lung and liver lesions
using a MLC (3, 4). A CyberKnife equipped with a mMLC
could even be more efficient in delivering noncoplanar be-
ams than gantry-based modalities, because time-consuming
manual couch adjustments would not be required. However,
a mMLC is not yet available for the CyberKnife.
The goal of the present study was first to assess the plan
quality and delivery time for computer-optimized noncopla-
nar 3D-CRT plans designed for a CyberKnife theoretically
equipped with a mMLC. The second goal was to compare
these mMLC plans with intensity-modulated plans devel-
oped for the currently available Iris collimator, only using
those node positions selected in the mMLC plans to generate
time-efficient treatment plans. To generate the Iris plans,
a dedicated inverse planning algorithm was developed in-
house for the present study.Organ Volume Dose
Spinal cord Any point 6 Gy/fraction
Liver Any point 8 Gy/fraction
Ipsilateral brachial
plexus
Any point 8 Gy/fraction
Esophagus Any point 9 Gy/fraction
Heart Any point 10 Gy/fraction
Trachea and main
bronchus
Any point 10 Gy/fraction
Ribs Any point 20 Gy/fraction
Lung <10% of total volume 20 Gy in total
Conformality constraint <1.2 * PTV 60 Gy in total
Abbreviation: PTV = planning target volume.METHODS AND MATERIALS
Patient group and dose prescriptions
The data from 10 lung cancer patients treated at our clinic with
the CyberKnife were used. These patients were also included in
the study by P€oll et al. (1). The gross target volume ranged from
5.9 to 78.0 cm3 (median, 14.1) and was delineated using the lung
level and window settings on computed tomography (CT). A gross
target volume to planning target volume (PTV)margin of 5mmwas
used to include microscopic extension of the tumor and to account
for inaccuracies of the Synchrony Respiratory Tracking System (5).
The PTV ranged from 20.8 to 152.3 cm3 (median, 40.5).The PTV was prescribed a dose of 60 Gy at an isodose level of
$80%, to be delivered in three fractions. At least 95% of the
PTV had to receive $60 Gy. The dose constraints for the organs
at risk were mainly defined by the Radiation Therapy Oncology
Group 0236 protocol for stereotactic radiotherapy for lung cancer
(6). These constraints are listed in Table 1. A conformality index
(CI) of #1.20 was required, defined as the ratio of the volume
receiving the prescription dose ($60 Gy) and the PTV.CyberKnife characteristics
One of the standard CyberKnife extracranial node sets was used,
which included 117 node positions. The node positions are distrib-
uted semispherically (noncoplanar) around the patient at a distance
to the imaging center of 800–1000 mm. Each node position effec-
tively acts as a focal spot position. The Iris variable aperture colli-
mator allows 12 field diameters to be used: 5, 7.5, 10, 12.5, 15, 20,
25, 30, 35, 40, 50, and 60mm defined at 800mm from the focal spot
(2). The 6-MV linear accelerator delivers an unflattened beam and
is calibrated such that 1 MU corresponds to a dose of 1 cGy in
a reference point located on the central axis of a 60-mm field, at
800 mm from the focal spot and a 15 mm depth in water.Step 1: mMLC plans generated using ‘‘Cycle’’
The mMLC plans for the CyberKnife were developed using
Cycle, an algorithm developed in-house for simultaneous optimiza-
tion of beam orientations, shapes, and weights (7). Cycle generates
treatment plans by sequential selection of beams from a set of user-
defined candidate beam orientations. Sequential selection means
that the planning process starts with an empty plan and that beams
are added one by one to the plan. In each iteration, the optimal beam
is selected from the candidate beam orientations using a weighted-
sum score function, which takes into account the imposed dose
constraints and the dose given by the beams previously added to
the plan. Favorable beam orientations can be selected more than
once, increasing the beam weight. The iterations are performed
until a feasible solution has been found (i.e., a solution that satisfies
all dose constraints). The minimization or maximization of plan
parameters can be achieved by repetitive application of Cycle,
each time adjusting the constraint until a feasible solution can no
longer be found.
In the present study, the candidate beamorientationswere defined
by the 117 node positions of the CyberKnife and the center of mass
of the tumor as the isocenter. The 3D-CRT fields were shaped,
assuming the use of a mMLC with a resolution of 2.5 mm at the
Fig. 1. Flow chart of inverse planning algorithm for Iris plans.
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the initial field shape for each beam. This field shape was subse-
quently optimized by extending or retracting the edges of the field
in four perpendicular lateral directions, according to de Pooter
et al. (8). Performing 3D-CRT requires the CyberKnife to be addi-
tionally equippedwith a flattening filter. Because such aCyberKnife
does not exist, the beam data from a gantry-based 6-MV linear ac-
celerator equipped with a mMLC and flattening filter was used,
normalized according to the CyberKnife conventions. The field
intensity was uniform, and the penumbrawas constructed by convo-
lution of the field intensity matrix with an off-axis kernel. The dose
was calculated on a rectangular dose gridwith a grid spacing of 33
 3 mm or 3  3  2 mm, depending on the CT slice spacing. An
equivalent path-length algorithmwas used to correct for density het-
erogeneities. After obtaining the final treatment plan, the dose was
recalculated using a grid spacing of 1  1  1.5 mm or 1  1  2
mm, depending on the CT slice spacing.Table 2. Average plan parameters of mMLC plans, MLD-equiv
Parameter mMLC MLD-equivale
MLD (Gy) 8.0 (4.8–12.3) 7.8 (4.3–12.3
V20 (%) 3.9 (2.4–6.7) 3.8 (2.1–6.4)
CI 1.20 (1.14–1.27) 1.17 (1.11–1.2
Node positions (n) 12.4 (10–16) 11.7 (10–14)
Beams (n) 12.4 (10–16) 63.5 (31–120)*
MUs (n) 11,690 (10,764–13,554) 21,990 (14,692–3
Fraction duration (min) 12.2 (10.8–13.5) 18.4 (12.9–28.
Abbreviations:mMLC = mini-multileaf collimator; MLD = biological
total lung volume receiving$20Gy; CI = conformality index (ratio of vol
unit; PTV = planning target volume.
* Significantly different (p < .05) from mMLC plans (Wilcoxon signeStep 2: Iris plans generated using inverse optimization
The treatment plans for the Iris collimator (Iris plans) were
generated using a new treatment planning algorithm for the Cyber-
Knife that has been developed in-house for the present study. A flow
chart of the planning algorithm is depicted in Fig. 1.
The planning process starts with the selection of candidate
beams, defined by a node position, a target point, and a collimator
size. For each node position, a projection of the PTVwasmade onto
a reference plane at 800 mm from the node position. The target
points were regularly distributed over the reference plane with
user-defined spacing. For all target points within the projected
PTV contour, all 12 collimator sizes were selected as candidate
beams. The target point spacing was set to 7–14 mm, depending
on the tumor size and number of node positions, to obtain 3,000–
4,000 candidate beams. For each patient, only those node positions
selected by Cycle in the mMLC plan were used for candidate beam
selection.
The next step is the construction of an individual dose matrix for
each structure involved in the optimization, containing the dose
deposited (in Gy/MU) in every voxel of the structure by every
candidate beam. It was constructed by performing dose calculations
for each element of the matrix, using the tissue maximal ratio/off-
axis ratio formalism and beam data from the CyberKnife. Density
heterogeneities were accounted for by calculating the equivalent
path length for each voxel. The use of separate dose matrices for
each structure allowed the dose grid spacing to be adjusted to the
size of the structure. The default grid spacing was set to 3  3 
3 mm or 3 3 2 mm, depending on the CT slice spacing. Smaller
grid spacing was used to ensure sufficient coverage or sparing of
small structures. Larger grid spacing was used for large structures
such as the lung. The final dose distribution in the entire patient
was recalculated using a dose grid spacing of 1  1  1.5 mm or
1  1  2 mm, depending on the CT slice spacing.
The core of the planning algorithm is the inverse multicriteria
optimization algorithm developed in-house by Breedveld et al.
(9). Using dose matrices and prescriptions as input, it is capable
of determining the optimal weights (in MU) of the candidate
beams. It makes a distinction in the prescriptions between the
constraints and objectives. The constraints are prescriptions that
must be fulfilled, otherwise the solution is invalid. Objectives are
prescriptions for which the optimal value (minimum or maximum)
is searched without violating the constraints. Minimization of the
total number of MUs was the only objective in the optimization
of the Iris plans. Because the linearity of the dose delivery cannot
be guaranteed at <5MU/fraction, the candidate beams should either
be ascribed$15 MU (in three fractions) or not selected at all. Thisalent Iris, CI-equivalent Iris plans, and preferred Iris plans
nt Iris CI-equivalent iris Preferred iris
)* 7.9 (4.0–12.2) 7.4 (4.0–11.4)*
3.9 (2.0–6.4) 3.6 (2.0–6.0)*
0) 1.17 (1.11–1.20) 1.15 (1.09–1.20)
11.8 (10–15) 11.5 (9–14)*
59.2 (34–120)* 59.6 (31–127)*
3,358)* 21,215 (14,692–31,217)* 21,961 (16,695–32,849)*
5)* 17.8 (12.9–28.5)* 18.1 (14.0–29.8)*
ly equivalent mean lung dose of 2 Gy fractions; V20 = percentage of
ume receiving prescription dose [$60Gy] and PTV);MU=monitor
d-rank test).
Fig. 2. Dose distributions of (A) mini-multileaf collimator plan and
(B) mean lung dose-equivalent Iris plan for Patient 4 (isocenter
slice). Thick white lines indicate planning target volume contour.
Depicted isodose lines ranged from 10% to 90% of maximal plan-
ning target volume dose.
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three times, each time excluding the beams that had been ascribed
#15 MU, until all remaining candidate beams had a weight of$15
MU. Typically, only a small fraction of the candidate beams (60–
360 beams) was not excluded. Because the CI constraint could not
be directly included in the optimization, a maximal dose constraint
on a shell structure around the PTV was used as a surrogate.
As can be seen in Fig. 1, the steps described are embedded in the
so-called resampling loop. Resampling is a method to improve the
optimality of a treatment plan by iteratively increasing the total
number of candidate beams (10). It makes use of the fact that
most of the candidate beams are excluded by the inverse optimiza-
tion, owing to the minimal beam weight of 15 MU. In each resam-
pling run, all excluded candidate beams were replaced by newly
selected candidate beams, after which the inverse optimization
was repeated. The new candidate beams were selected by repeating
the candidate beam selection using a target point spacing lowered
by 1 mm. A decreasing target point spacing results in an increasing
number of candidate beams and resampling was terminated when
the maximum of 10,000 candidate beams was exceeded. Resam-
pling was also terminated when the improvement in the number
of MUs was <1%.
The final optimization step is the minimization of the total
number of beams in the treatment plan, indicated by the beam reduc-
tion loop in Fig. 1. During beam reduction, the inverse optimization
was performed repeatedly, each time excluding beams with the low-
est contribution, until a feasible solution could no longer be found.
The contribution of a beam was defined as the dose delivered to the
isocenter, if the beam would have been targeted at the isocenter.Fig. 3. Estimated treatment time/fraction as function of planning
target volume for all 10 patients. Lines indicate linear fits to data
(mini-multileaf collimator, R2 = 0.04, p = .6; mean lung dose-
equivalent Iris, R2 = 0.62, p = .007; conformity index-equivalent
Iris, R2 = 0.81, p < .001; t test, null-hypothesis, slope = 0).Plan evaluation
All treatment plans were inspected by a physician and only clin-
ically acceptable plans were included. The quality of the treatment
plans was assessed using the biologic equivalent mean lung dose of
2 Gy fractions (MLD), total lung volume receiving $20 Gy, CI,
number of node positions, number of beams, total number of
MUs, and estimated treatment time for each fraction. The MLD
is the most accurate parameter to predict the incidence of radiation
pneumonitis and was calculated using the linear quadratic model
(a/b = 3 Gy for the lung) (11). The estimated treatment time for
each fraction was calculated using a dedicated algorithm that
included the beam-on time, robot motion time, and time needed
for imaging during treatment. It assumed a dose rate of 800 MU/
min, a CyberKnife G4 robot speed, and approximately 5 s/image
pair, acquired every three beams. Because the CyberKnife is not
equipped with a flattening filter, the beam-on time of the mMLC
plans was increased by 20% to account for flattening of the fields,
according to the off-axis profile of the uncollimated CyberKnife
beam. The treatment time estimations did not include the time
needed for patient setup or for building a correlationmodel between
the positions of the implanted markers and external markers on the
patient’s chest (5).
TheMLDwas used as primary objective in the comparison of the
mMLC and Iris plans. For each patient, the MLD was minimized in
the mMLC plan and an equal MLD was aimed at in the MLD-
equivalent Iris plan. In addition, several Iris plans with varying
MLD constraints were developed for each patient. A relaxed
MLD constraint (15 Gy) was described for the first plan and was
lowered by 0.5 Gy in successive Iris plans until a feasible treatment
plan could no longer be found, thereby, resulting in the range of
MLD values that can be obtained within other constraints. From
all Iris plans, a CI-equivalent Iris plan was selected, having a CIclosest to that of the mMLC plan. Finally, the physician selected
the one preferred Iris plan from all Iris plans for each patient that
in the physician’s opinion provided the optimal balance between
the plan quality and treatment time.RESULTS
Table 2 lists the average plan parameters for the mMLC
plans, the MLD-equivalent Iris plans, the CI-equivalent
Iris plans, and the preferred Iris plans. Cycle selected 10–
16 node positions in the mMLC plans, depending on the
patient. These node positions were subsequently used in
the generation of the Iris plans. The average estimated treat-
ment time/fraction was 12.2 min for the mMLC plans and
18.4 min for the MLD-equivalent Iris plans. When the CI
was used as similarity measure, the results differed little
Fig. 4. Mean lung dose (MLD) as function of estimated fraction
duration of mini-multileaf collimator plan and Iris plans. Each
marker represents single treatment plan. Solid black markers indi-
cate preferred Iris plans selected by physician.
Fig. 5. Box plots of relative use of field sizes in mean lung dose-
equivalent Iris plans of all patients, measured in number of beams
and monitor units delivered. Whiskers indicate extreme values.
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selected as being equivalent. The preferred Iris plans
selected by the physician had a lower MLD than theMLD-equivalent Iris plans, and a treatment time/fraction
of 18.1 min on average.
During Iris plan generation, the inverse planning algo-
rithm performed an average of 7 resampling runs, thereby in-
creasing the total number of candidate beams from 3,300 to
31,000 on average. The number of MUs was consequently
reduced by an average of 28% compared with treatment
planning without resampling. The beam reduction resulted,
on average, in the use of 42% fewer beams at the cost of
an increase in the number of MUs of only 5%. In 2 patients,
the tumor was located within 2 cm of the spinal cord. The
conformality constraint was sacrificed in the mMLC plans
of these 2 patients to improve the sparing of the spinal
cord. Moreover, The spinal cord constraint was relaxed to
8 Gy/fraction in one of these patients. The rib constraint
was relaxed in the mMLC and Iris plans of 3 patients who
had one or two ribs located partially within the PTV, because
the PTV coverage was given the greatest priority. The dose
distributions of the mMLC plan and MLD-equivalent Iris
plan of Patient 4 are given in Fig. 2.
The variation in the fraction durations of the mMLC plans
was small, but they varied greatly for the Iris plans (Fig. 3).
Figure 3 shows that the fraction duration increased with an
increasing target volume when using circular fields, similar
for MLD-equivalent Iris plans (p = .007) and CI-equivalent
Iris plans (p < .001). When conformally shaped fields were
applied, the treatment time for each fraction was not signif-
icantly influenced by the target volume (p = .6). Thus, the
fraction duration of MLD-equivalent plans was, on average,
40% longer than that of the mMLC plans for tumors <80 cm3
and #121% longer for larger targets. For 1 patient, the Iris
plan (same plan as for the MLD-equivalent and CI-
equivalent plans) was more time-efficient than the mMLC
plan. For this patient, this could be explained by the fact
Fig. 6. Targeting of beams from node positions in mean lung dose-equivalent Iris plan of Patient 4. For each node
position, beam’s eye view projection of planning target volume given in black, and field contour (50% isodose) of
each beam in red.
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of the mMLC plan. Although Iris plan generation started
with all the node positions of the mMLC plan, some node po-
sitions were not selected by the inverse optimization algo-
rithm. This was also observed in 5 other patients, but to
a much lesser extent.
In Fig. 4, the MLD is plotted as a function of the estimated
fraction duration for the mMLC plan (with a minimized
MLD) and all Iris plans (with various MLD constraints) of
each patient. The solutions in the lower part of each Iris
graph are Pareto-efficient in terms of the MLD and fraction
duration. Thus, a reduction in MLD was inevitably accom-
panied by an increase in the fraction duration and vice versa.However, this Pareto-efficiency no longer holds for a greater
MLD, because the solutions are restricted by different con-
straints in both regions of the graphs. The prescribed MLD
is the limiting constraint in the lower part of the graphs,
and the CI constraint is limiting in the upper part. The CI
constraint also restricts the maximal MLD that can be
obtained, which, in 2 patients, was even lower than the min-
imized MLD of the mMLC plan. The lowest MLD in all
patients was obtained using the Iris collimator.
On average, nine collimator sizes were used in the MLD-
equivalent Iris plans. Figure 5 shows the relative use of the
collimator sizes, measured in the number of beams and in
the number of MUs delivered. The smallest collimator size
Fig. 7. Delivered fluence corresponding to Fig. 6. Beam’s eye view projection of planning target volume given in black.
Fluences normalized to maximal fluence for each node position.
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mm were present in every treatment plan. A collimator
size of 35 mm was, on average, most frequently used. The
four largest collimator sizes delivered more MU/beam than
the smaller collimators. Figure 6 shows the targeting of
beams in the MLD-equivalent Iris plan of Patient 4. The
large fields were typically aimed at the center of the PTV,
and the smaller beams were used to deliver the dose at the
PTV periphery. The corresponding fluence profiles of each
node position are given in Fig. 7. Considerable fluence
variation (i.e., intensity modulation) was be observed within
almost all fields delivered from each node position.DISCUSSION
The use of a mMLC on the CyberKnife was found to give
time-efficient treatment plans in lung cancer patients. Iris
plans generally had a greater treatment time/fraction, espe-cially in large tumor volumes. Both the mMLC and Iris plans
were much more time-efficient than the traditional fixed-
collimator plans, which contain, for these patients, approxi-
mately 60 nodes positions, 125 beams, and 35,000MUs. The
Iris plans are also likely to be more time-efficient than the
two-collimator plans from the study by P€oll et al. (1) for
the same patient group. The Iris plans contained an average
of 47% fewer beams and 2% more MUs. Although the num-
ber of node positions in the two-collimator plans was not re-
ported, it is evidently expected to be much greater than in the
Iris plans. The average MLD and CI were also considerably
lower in the Iris plans.
The mMLC plans and Iris plans were generated using two
different planning algorithms. Therefore, our observations
could be biased by differences in these algorithms. As
both algorithms were developed in-house, the parts of the al-
gorithms such as structure segmentation, heterogeneity cor-
rection, dose grids, and plan evaluation, were deliberately
870 I. J. Radiation Oncology d Biology d Physics Volume 81, Number 3, 2011kept similar. However, some differences were inevitable, be-
cause the algorithms had to serve a different purpose (beam-
angle optimization vs. inverse optimization for given node
positions) and had to manage different field characteristics
(isocentric conformal uniform beams vs. nonisocentric cir-
cular nonuniform beams). Another limitation of the present
study was that a CyberKnife equipped with a mMLC and
a flattening filter does not exist. The beam model, derived
from a 6-MV gantry-based stereotactic linear accelerator,
could therefore not be verified with a real machine. We fur-
thermore assumed the use of an idealized mMLC. Instead of
performing actual leaf segmentation, an arbitrarily orien-
tated collimator grid was used with 2.5-mm resolution.
Moreover, the mMLC was assumed to perfectly block the
beam.
In the present study, we used flattened fields for the
mMLC plans. Unflattened fields are becoming more com-
mon but require intensity modulation to cope with the
nonuniform beam profiles, especially for larger tumors.
The use of intensity-modulated radiotherapy (IMRT) on
conventional gantries caused the delivery time to increase
considerably compared with that for 3D-CRT. Because the
aim of the present study was to improve the time efficiency
of the CyberKnife treatments, we benchmarked the Iris plans
with flattened nonintensity-modulated fields. To account for
a flattening filter, the beam-on time was increased by 20%.
The estimated mMLC fraction duration was, however, rather
insensitive to this assumption. If a dose rate loss of 30% was
assumed instead, the average mMLC treatment time would
increase by only 4%. The use of flattened and unflattened
fields in relation to plan quality and treatment time is the
subject of future research.The mMLC plans were not reproduced exactly by the Iris
plans. This was, for example, illustrated by the dose distribu-
tions in Fig. 2 and by the fact that not all node positions of the
mMLC plans were selected in the Iris plans. Moreover,
Fig. 7 shows that the fluence profiles were highly modulated
in the Iris plans. In contrast, a uniform fluence was used in
the mMLC plans. Thus, the dosimetric plan quality of the
Iris plans could be superior to that of the mMLC plans. How-
ever, it raises the question of whether the node positions
selected by Cycle were optimal for use in the Iris plans. de
Pooter et al. (4) used a similar approach for liver tumors,
in which the selection of beam orientations by Cycle was
followed by inverse IMRT optimization. The two-step opti-
mization of beam orientations and IMRT profiles was, in
some cases, found to result in suboptimal treatment plans.
It is, therefore, likely that the quality of the Iris plans can
be improved further if the beam orientation selection is inte-
grated into the inverse planning algorithm. Simultaneous
orientation and profile optimization for IMRT and Cyber-
Knife are currently being developed at our institute.CONCLUSION
Noncoplanar robotic stereotactic radiotherapy using
amMLCwas found to give very time-efficient treatment plans
in lung cancer patients. For small target volumes (<80 cm3),
the Iris variable-aperture collimator is a time-efficient alterna-
tive to a mMLC. The fraction duration of these Iris plans
(MLD-equivalent) was, on average, 40% longer than mMLC
plans, with similar or better plan quality. For larger tumors,
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